30 November 2023 to 1 December 2023
Verkehrshaus der Schweiz
Europe/Zurich timezone

Session

Session V

1 Dec 2023, 13:30
Konferenzsaal Coronado (Conference Center)

Konferenzsaal Coronado

Conference Center

Presentation materials

There are no materials yet.

  1. Michele Zeverino (CHUV)
    01/12/2023, 13:30
    Radiation Therapy
    Oral

    Purpose: To develop an auto-planning strategy for right-sided breast treatments by adapting the deep learning-based predicted dose from a pre-existing left-sided breast model.
    Methods: The procedure was executed in RayStation v12A TPS and applied to early breast cancer treatments delivering 48Gy/42.4Gy in 16 fractions for PTVBoost and PTVBreast, respectively. Initially, the predicted dose...

    Go to contribution page
  2. Raphael Joost (Division of Medical Radiation Physics and Department of Radiation Oncology, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland)
    01/12/2023, 13:40
    Radiation Therapy
    Oral

    Purpose: To develop a fast, deep-learning based Monte Carlo dose distributions (MCDD) denoising framework for 6, 10 and 15 MV volumetric modulated arc therapy (DeepSMCP) and integrate it into the Swiss Monte Carlo Plan (SMCP).

    Methods: DeepSMCP is integrated into the SMCP framework as an additional dose-calculation algorithm and can be selected using the SMCP’s graphical user...

    Go to contribution page
  3. Katerine Viviana Diaz Hernandez (University of Zurich)
    01/12/2023, 13:50
    Radiation Therapy
    Oral

    Purpose
    The objective of this study is to assess the feasibility of automated O-Ring Halcyon Linac SBRT plans for lung metastases and determine a Planning Target Volume (PTV) threshold as an indicator of plan quality. The study also contrasts plan quality and treatment durations between Halcyon Linac (HAL) and CyberKnife (CK) robotic SBRT.
    Methods
    A total of 17 previously treated CK lung...

    Go to contribution page
  4. Nathan Torelli (Department of Radiation Oncology, University Hospital Zurich and University of Zurich)
    01/12/2023, 14:00
    Radiation Therapy
    Oral

    Purpose: The selection of the collimator angle for linac-based stereotactic radiosurgery (SRS) of multiple brain metastases (BMs) is important to reduce the bridge dose in between the different lesions and minimize brain toxicities. In this work, we developed an algorithm which simultaneously optimizes the dose distribution and the collimator angle for SRS of multiple BMs.

    Methods:...

    Go to contribution page
  5. Florian Dietsche
    01/12/2023, 14:10
    Radiation Therapy
    Oral

    Purpose: Research treatment planning systems (TPS) are needed for further development of optimization algorithms and exploration of novel concepts not supported by commercial TPS. However, research TPS are not approved medical products and lack the rigorous testing of commercial TPS. In this work, we developed a tool to upload treatment plans generated with our in-house TPS into the...

    Go to contribution page
  6. Térence Risse (Réseau Hospitalier Neuchâtelois)
    01/12/2023, 14:20
    Radiation Therapy
    Oral

    Purpose
    The aim of this project is to verify the entire treatment quality of Ethos (Varian, Pola Alto, USA) online adaptive radiotherapy (oART).

    Methods
    An end-to-end test, specifically designed for oART, was conducted with a water-equivalent 3D printed pelvis phantom. Five organs were included in this phantom: bladder, prostate, rectum and femoral heads. The organs were modeled...

    Go to contribution page
  7. Katarzyna Czerska (PSI - Paul Scherrer Institut)
    01/12/2023, 14:30
    Radiation Therapy
    Oral

    Purpose:
    Daily adaptive proton therapy (DAPT) differs significantly from established processes in conventional radiotherapy. Online adaptation is technologically challenging, needs to be fast and automated and involves new, non-routine steps (e.g., daily plan re-optimization). Therefore, a tailored design of the DAPT workflow, including QA procedures, is required to ensure its safe clinical...

    Go to contribution page
Building timetable...